Goblet-cell hyperplasia is a critical pathological feature in hypersecretory diseases of airways. However, the underlying mechanisms are unknown, and no effective therapy exists. Here we show that stimulation of epidermal growth factor receptors (EGF-R) by its ligands, EGF and transforming growth factor ␣ (TGF␣), causes MUC5AC expression in airway epithelial cells both in in vitro and in vivo. We found that a MUC5AC-inducing epithelial cell line, NCI-H292, expresses EGF-R constitutively; EGF-R gene expression was stimulated further by tumor necrosis factor ␣ (TNF␣). EGF-R ligands increased the expression of MUC5AC at both gene and protein levels, and this effect was potentiated by TNF␣. Selective EGF-R tyrosine kinase inhibitors blocked MUC5AC expression induced by EGF-R ligands.
glycine, and 20% (vol͞vol) methanol (pH 8.3). The proteins were then transferred electrophoretically to nitrocellulose membranes. The membranes were incubated with 5% fat-free skim milk in PBS containing 0.05% Tween 20 for 1 h and incubated with monoclonal mouse anti-EGF-R antibody (1:100, Calbiochem) at 4°C overnight. Bound antibody was visualized according to standard protocols for the avidinbiotin-alkaline phosphatase complex method (ABC kit, Vector Laboratories). As a positive control for EGF-R, cell lysates from A431 cells were used (18) .
Immunocytochemical localization of EGF-R and MUC5AC in NCI-H292 cells. Cells grown on 8-chamber slides were fixed with 4% paraformaldehyde for 1 h. PBS containing 0.05% Tween 20, 2% normal goat serum, and Levamisol (2 mM) was used as diluent for the antibody. Cells were incubated with mouse mAb to EGF-R (1:250) or to MUC5AC (clone 45 M1, 1:100, New Markers, Fremont, CA) overnight at 4°C, and then washed 3 times with PBS to remove excess primary antibody. Cells were then incubated with biotinylated horse anti-mouse IgG (Vector Laboratories) at 1:200 dilution for 1 h at room temperature. Bound antibody was visualized according to standard protocols for avidin-biotin-alkaline phosphatase complex method.
Mucin analysis. Cells were fixed similarly to the immunocytochemical technique and stained with Alcian blue͞periodic acid-Schiff (AB-PAS). MUC5AC protein was measured by using ELISA. Cell lysates were prepared with PBS at multiple dilutions, and 50 l of each sample was incubated with bicarbonate-carbonate buffer (50 l) at 40°C in a 96-well plate (Nunc), until dry. Plates were washed three times with PBS and blocked with 2% BSA, fraction V (Sigma) for 1 h at room temperature. Plates were again washed three times with PBS and then incubated with 50 l of mouse monoclonal MUC5AC antibody (1:100), which was diluted with PBS containing 0.05% Tween 20, and dispensed into each well. After 1 h, the wells were washed three times with PBS, and 100 l of horseradish peroxidase-goat anti-mouse lgG conjugate (1:10,000) was dispensed into each well. After 1 h, plates were washed three times with PBS. Color reaction was developed with 3,3Ј,5,5Ј-tetramethylbenzidine (TMB) peroxidase solution (Kirkegaard & Perry Laboratories) and stopped with 1 M H 2 SO 4 . Absorbance was read at 450 nm.
Northern blotting. Total RNA was extracted from NCI-H292 cells grown in a T-75 tissue culture flask in each condition, using Trizol (GIBCO). Total RNA (10 g) was electrophoresed on 1% agarose͞formaldehyde gel and transferred to a nylon membrane (Amersham Pharmacia) by capillary blotting. The probes (pTRI-EGF-R-human probe template, Ambion, Austin, TX; and human MUC5AC, generously provided by Carol Basbaum, University of California, San Francisco) were labeled with 32 P by using the Random Primed DNA labeling kit (Boehringer Mannheim). Hybridization was performed as described (19) .
In Vivo Studies. The experimental animal protocol was approved by the Committee on Animal Research, University of California, San Francisco. Specific pathogen-free male F344 Fisher rats, weighing 230-250 g (Simonsen Laboratories, Gilroy, CA), were maintained in a temperature-controlled (21°C) room with standard laboratory food and water freely available.
Healthy rats. Rats were anesthetized with methohexital sodium (Brevital sodium, 50 mg͞kg, i.p.; Eli Lilly) and allowed to breathe spontaneously. TNF␣ (200 ng, 100 l) was instilled into the trachea, and the animals were euthanized 24 h later. EGF (600 ng, 100 l) or TGF␣ (rat synthetic TGF␣, 250 ng, 100 l; Sigma) was instilled into the trachea either alone or 24 h after the instillation of TNF␣ (200 ng, 100 l), and the animals were euthanized 48 h later. In each study, sterile PBS (100 l) was instilled into the trachea as control. In inhibition studies, rats were pretreated with BIBX1522 (3, 10, or 30 mg͞kg, i.p., dose estimated from studies using the inhibitor to prevent cancer growth), 1 h before and 24 h after instillation of TGF␣. The trachea and lungs were removed for examination 48 h after the instillation of TGF␣.
Sensitized rats. Rats were sensitized on days 0 and 10 with intraperitoneal injections (i.p.) of ovalbumin (10 mg, grade V; Sigma), complexed with 100 mg of aluminum hydroxide in 0.5 ml of sterile saline. On days 20, 22, and 24, ovalbumin (0.1%, 100 l) was delivered by intratracheal (i.t.) instillation. Rats were euthanized either without i.t. instillation (day 20) or 48 h after the third i.t. instillation (day 26). To study the effect of BIBX1522 on goblet-cell production in sensitized rats, BIBX1522 was given i.p. (10 mg͞kg) 1 h before the i.t. instillation of ovalbumin and instilled into the trachea (10 Ϫ5 M, 100 l) on days 20, 22 and 24. BIBX1522 was also injected i.p. (10 mg͞kg) every 24 h until the day before the rats were euthanized. Forty-eight hours after the third i.t. instillation, the animals were euthanized, and the trachea and lungs were removed.
Tissue preparation. At preselected times during anesthesia, the systemic circulation was perfused with 1% paraformaldehyde in DEPC-treated PBS at a pressure of 120 mmHg (1 mmHg ϭ 133 Pa). For frozen sections, tissues were removed and placed in 4% paraformaldehyde for 1 h and placed in 30% sucrose for cryoprotection overnight. The tissues were embedded in optimal cutting temperature (OCT) compound. For plastic sections, the tissues were placed in 4% paraformaldehyde for 24 h then dehydrated and embedded in JB-4 plus monomer solution A. The embedded tissues were cut as cross sections (4 m thick) and placed on glass slides.
Cell analysis. The total number of epithelial cells was determined by counting epithelial cell nuclei over 2 mm of the basal lamina with an oil immersion objective lens (ϫ1,000 magnification). The linear length of the basal lamina under each analyzed region of epithelium was determined by tracing the contour of the digitized image of the basal lamina. The epithelial cells were identified as described (20, 21) . In brief, goblet cells are goblet to low columnar in shape, with abundant AB-PAS-stained granules filling most of the cytoplasm. Pregoblet cells contain smaller mucus-stained areas (Ͻ1͞3 height in epithelium from basement membrane to luminal surface) or sparse granules stained with AB-PAS. Ciliated cells are recognized by their ciliated borders, lightly stained cytoplasm, and large, round nuclei. Nongranulated secretory cells are columnar in shape and extend from the lumen to the basal lamina. The cytoplasm stains light pink, and a few small, PAS-positive and AB-negative granules are observed in the cytoplasm. Basal cells are small, flattened cells with large nuclei located just above the basal lamina but not reaching the airway lumen.
Quantification of goblet-cell production. Goblet-cell production was determined by the volume density of AB-PAS-stained mucous glycoconjugates on the epithelial mucosal surface, by using a semiautomatic imaging system described elsewhere (22) . We measured the AB-PAS-positive stained area and the total epithelial area and expressed the data as the percentage of the total area stained by AB-PAS. The analysis was performed with the public domain NIH IMAGE program (developed at the U.S. National Institutes of Health and available by anonymous FTP from zippy.nimh.gov or on floppy disk from the National Technical Information Service, Springfield, VA, part number PB95-500195GEI).
Immunohistochemical localization of EGF-R in rat epithelium. The localization of EGF-R was examined by using immunohistochemical staining with an antibody to EGF-R (Calbiochem) in frozen sections of rat trachea. Immunostaining was performed similarly to the in vitro studies.
In situ hybridization. The cDNA for rat MUC5AC was generously provided by Carol Basbaum. A 320-bp cDNA fragment of rat MUC5AC was subcloned into the XbaI͞HindIII site of the transcription vector, pBluescript-SK(Ϫ) (Stratagene). The preparation of RNA probes and in situ hybridization were performed as described (20) . Statistics. All data are expressed as mean Ϯ SEM. One-way ANOVA was used to determine statistically significant differences between groups. Scheffe's F test was used to correct for multiple comparisons when statistical significances were identified in the ANOVA. A probability of Ͻ0.05 for the null hypothesis was accepted as indicating a statistically significant difference.
RESULTS

TNF␣ Stimulates Production of EGF-R in NCI-H292 Cells.
First, we determined whether NCI-H292 cells express EGF-R constitutively. Immunoblot analysis of cell lysates identified the presence of EGF-R protein in confluent cultures of NCI-H292 cells (Fig. 1A) . Protein from A431 cells provided a positive control for EGF-R ( Fig. 1 A) ; these cells express EGF-R constitutively (18) . Immunocytochemical analysis with an anti-EGF-R antibody revealed that most cells were positive, although some cells had more intense staining than the others (Fig. 1B) . Northern blotting in NCI-H292 cells showed little expression of EGF-R mRNA constitutively, but TNF␣ upregulated EGF-R mRNA at 12 h, accentuated at 24 h (Fig. 1C) .
EGF-R Ligands Stimulate MUC5AC Protein and Gene Expression in NCI-H292 Cells. EGF-R are expressed constitutively in NCI-H292 cells; we assessed the ability of EGF-R ligands (EGF and TGF␣) to induce mucous glycoconjugate production (assessed by AB-PAS staining; Fig. 2 , upper column): Some control cells showed AB-PAS staining; incubation with either EGF or with TGF␣ increased PAS-positive staining; incubation with TNF␣ alone did not affect staining (data not shown). However, TNF␣ potentiated the stimulatory effect of EGF-R ligands on mucous glycoconjugate production (Fig. 2) . Immunocytochemical analysis with an anti-MUC5AC antibody showed that the cytoplasm of a few control cells stained positive, similar to AB-PAS staining. Incubation with TNF␣ plus TGF␣ increased the staining for MUC5AC protein in a pattern similar to AB-PAS staining (Fig. 2, Lower) . To quantify the MUC5AC production, an ELISA was performed: EGF alone or TGF␣ alone caused an Ϸ2-fold increase in MUC5AC production. Thus, EGF-R ligands induce the production of MUC5AC protein in NCI-H292 cells. TNF␣ alone caused little increase in MUC5AC, but TNF␣ potentiated the effect of EGF-R ligands (Fig. 3) . To examine MUC5AC gene expression, Northern blotting was performed. MUC5AC gene was expressed at low levels in NCI-H292 cells treated with control medium. Incubation with EGF or TGF␣ increased MUC5AC gene expression beginning at 12 h and reaching a maximum at 24 h. TNF␣ alone had no effect on MUC5AC gene 3 . ELISA for MUC5AC in NCI-H292 cells. MUC5AC protein was measured as described in Methods. TNF␣ caused little expression of MUC5AC protein (8.7 Ϯ 3.8%, n ϭ 3); TGF␣ alone caused Ϸ100% increase in MUC5AC protein, an effect that was potentiated by coincubation with TNF␣ (149.5 Ϯ 21.7%, n ϭ 6). The stimulatory effect of TNF␣ plus TGF␣ was inhibited by each of the three selective EGF-R tyrosine kinase inhibitors (BIBX1522, Ϫ6.0 Ϯ 5.5%; tyrphostin AG1478, 2.1 Ϯ 6.7%; Compound 56, 1.0 Ϯ 14.5%; n ϭ 3), whereas a negative control for tyrphostins (tyrphostin A1) and a selective inhibitor of platelet-derived growth factor (tyrphostin AG1295) were without effect. expression but greatly potentiated the stimulatory effect of EGF-R ligands; TGF␣ showed a greater effect than EGF (Fig. 4) .
EGF-R Tyrosine Kinase Inhibitors Prevent MUC5AC Gene and Protein Expression in NCI-H292 Cells.
To test the hypothesis that activation of EGF-R induces MUC5AC gene and protein expression, cells were incubated with various tyrosine kinase inhibitors. Pretreatment of NCI-H292 cells with selective kinase inhibitors for EGF-R (BIBX1522, AG1478, Compound 56) prevented the increased staining for MUC5AC protein that usually occurred with EGF-R ligands (Fig. 3) . A selective tyrosine kinase inhibitor of plateletderived growth factor (AG1295) and a negative control for tyrphostins (A1) were without effect (Fig. 3) . On Northern analysis, BIBX1522 completely inhibited MUC5AC gene expression caused by the combination of TNF␣ plus EGF-R ligands (Fig. 4) . These results implicate activation of EGF-R tyrosine kinase in the induction of MUC5AC gene and protein expression in NCI-H292 cells.
TNF␣ Stimulates EGF-R Production in Rat Airways. In the control state, tracheal epithelium contained few EGF-Rpositive cells (Fig. 5A, Left) . However, intratracheal instillation of TNF␣ induced EGF-R protein in the tracheal epithelium (Fig. 5A, Right) .
Role of EGF-R Ligands in Mucous Glycoconjugate Production and MUC5AC Gene Expression in Rats.
In the control state, tracheal epithelium contained few goblet and pre-goblet cells. Intratracheal instillation of EGF-R ligands (EGF or TGF␣) alone had no effect on goblet cell production (Table 1) . However, when TNF␣ was given first, followed 24 h later by TGF␣ or by EGF (data not shown), the numbers of goblet and pre-goblet cells were increased markedly; the numbers of nongranulated secretory cells and basal cells decreased significantly, whereas there was no change in the total number of cells or in the number of ciliated cells (Table 1) . In situ hybridization for MUC5AC gene showed no expression in control animals. When TNF␣ was instilled intratracheally, followed by EGF or TGF␣, expression of MUC5AC was visible in the epithelium (data not shown). Thus, induction of EGF-R alone or stimulation by EGF-R ligands alone was insufficient to induce goblet-cell production. However, after the induction of EGF-R by TNF␣, instillation of EGF-R ligands stimulated goblet-cell production markedly.
Ovalbumin Sensitization in Rats Induces EGF-R and Goblet-Cell Production.
Injections of ovalbumin i.p. on days 0 and 10 did not alter the total number of epithelial cells and did not increase the number of goblet cells or pre-goblet cells (Table  1) . However, when this was followed by three i.t. instillations of ovalbumin on days 20, 22, and 24, the total number of epithelial cells increased significantly compared with control state. The numbers of goblet and pre-goblet cells were increased markedly, but the numbers of ciliated and basal cells were unchanged (Table 1) . Thus, ovalbumin i.p. followed by ovalbumin i.t. caused goblet cell hyperplasia. Immunohistochemical studies with an anti-EGF-R antibody showed no staining in control tracheas (data not shown). Animals sensitized to both i.p. and i.t. showed EGF-R staining (Fig. 5B, Left) selectively in cells that stained positively with AB-PAS (Fig.  5B, Right) .
EGF-R Tyrosine Kinase Inhibitor, BIBX1522 Prevents Goblet-Cell Production Induced by Instillation of TNF␣ Plus EGF-R Ligands and by Ovalbumin Sensitization in Rats.
Because BIBX1522 prevented mucin production in cultured cells, the effect of this inhibitor was examined in pathogen-free rats. Alcian blue-PAS staining, which was increased by tracheal instillation of TNF␣ followed by EGF-R ligand TGF␣, was inhibited dose-dependently by pretreatment with BIBX1522 (Fig. 6A) . Similarly, three i.t. instillations of ovalbumin caused a significant increase in goblet-cell production, which was inhibited by pretreatment with BIBX1522 (Fig. 6B) .
DISCUSSION
We investigated the role of EGF-R and its ligands in mucin production in airway epithelium by using NCI-H292 cells (23) and by using pathogen-free rats whose airways contain few goblet cells. TNF␣ induced expression of EGF-R in both NCI-H292 cells and rat-airway epithelial cells. After induction of EGF-R by TNF␣, subsequent stimulation of EGF-R by its ligands resulted in MUC5AC production at both gene expression and protein levels. Selective inhibitors of EGF-R tyrosine kinase blocked MUC5AC gene and protein expression caused by TNF␣ plus EGF-R ligands, suggesting that EGF-R signaling is involved in MUC5AC production.
The mechanism by which TNF␣ acted on MUC5AC gene and protein expression in NCI-H292 cells requires discussion. In our studies, TNF␣ alone had little effect on MUC5AC production, although one study reported that TNF␣ induces mucin MUC2 gene expression (24) . Our results show that TGF␣ had a large effect on MUC5AC gene expression, and that the effect of TGF␣ was markedly potentiated by coincubation with TNF␣. The effect of TNF␣ plus TGF␣ was greater than additive. A possible explanation for the potentiating effect of TNF␣ is the up-regulation of EGF-R. In fact, TNF␣ caused EGF-R gene expression in NCI-H292 cells; similar findings are reported in A431 cells (15) , human pancreatic cancer cells (14) , and epidermal keratinocytes (16) . The fact that the inhibition of EGF-R tyrosine kinase completely blocked MUC5AC gene and protein expression caused by TNF␣ plus EGF-R ligands implicates the EGFR pathway in the TNF␣-TGF␣ responses. Two other selective EGF-R tyrosine kinase inhibitors (AG1478 and C56) also inhibited MUC5AC protein production, similar to BIBX1522. However, a selective platelet-derived growth factor tyrosine kinase inhibitor (AG1295) and a negative control for tyrphostins (A1) were without effect, implicating EGF-R tyrosine phosphorylation as the signaling pathway inducing MUC5AC expression.
Present results also suggest a possible sequence for the evolution of goblet-cell production based on the expression of EGF-R: Stimulation with TNF␣ induced intense EGF-R staining of nongranulated secretory cells; their subsequent activation by EGF-R ligands caused progressive staining for mucous glycoconjugates, and the cells became ''pre-goblet'' and then ''goblet'' cells. Instillation of TNF␣ followed by EGF-R ligands induced goblet-cell production without altering the total number of epithelial cells, suggesting that EGF-R activation promoted selective cell differentiation (not proliferation). These findings suggest that goblet cells are derived from nongranulated secretory cells that express EGF-R and are stimulated by EGF-R ligands to produce mucins. In our study, sensitization caused goblet cell production associated with an increase of the total number of cells in airway epithelium, whereas instillation of TNF␣ and TGF␣ caused goblet cell production but not epithelial hyperplasia. One reason for the difference may be the duration after the stimulus. A second reason for the difference may be because of the presence of another mediator that causes epithelial cell proliferation in the sensitized animal, such as cysteinyl leukotrienes, which are increased in asthmatic airways (25) . We show that EGF-R are not expressed in control airway epithelium but are expressed in sensitized airways. Cells that stained were pre-goblet and goblet cells, suggesting that EGF-R is involved in goblet cell production. Pretreatment with BIBX1522 prevented airway goblet cell production, confirming the role of EGF-R activation in goblet cell production in experimental asthma. However, two issues , 100 l) . Tracheal instillation of TNF␣, followed by the EGF-R ligand TGF␣, increased goblet-cell production significantly (n ϭ 5; ‫,ء‬ P Ͻ 0.0001), an effect that was inhibited by pretreatment with BIBX1522 (3-30 mg͞kg, i.p.) dose-dependently (n ϭ 5; P compared with TNF␣ followed by TGF␣: † , P ϭ 0.003; † † , P Ͻ 0.0001). (B) Ovalbumin sensitization. Animals given ovalbumin intraperitoneally (i.p.) only showed little AB-PAS-positive staining in bronchial epithelium. Animals first sensitized with ovalbumin (OVA) i.p., followed by three intratracheal (i.t.) instillations of OVA, showed a marked increase in AB-PAS-positive staining (n ϭ 5; ‫,ء‬ P Ͻ 0.0001). Pretreatment with BIBX1522 (10 mg͞kg, i.p.) inhibited OVA-induced production of goblet cells (n ϭ 5; † † , P Ͻ 0.0001). remain. (i) The mechanism of expression of EGF-R: TNF␣ is a likely candidate; it is produced by mast cells (26) , neutrophils (27) , and macrophages (28) and is elevated in bronchoalveolar lavage fluid obtained in subjects with symptomatic asthma (29) ; and (ii) The source of EGF-R ligands: in asthmatics, epithelial cells are reported to express EGF (13); another possible source is leukocytes, because eosinophils (30), neutrophils, and monocytes (31) produce EGF-R ligands. In our study, i.p. sensitization with ovalbumin did not cause gobletcell hyperplasia, but airway instillation of ovalbumin in sensitized rats, which results in leukocyte recruitment (32) , caused goblet-cell production. This result suggests a possible role in leukocytes as a source of EGF-R ligands. Previous studies showed that various stimuli such as ozone (33) , sulfur dioxide (34), viruses (34) , lipopolysaccharide (33, 35) , and platelet activating factor (20) up-regulate mucin expression and secretion. Recently, downstream signaling causing mucin MUC2 expression induced by Pseudomonas aeruginosa was shown to go through a c-Src-Ras-MEK1͞2-MAPK-pp90rsk pathway (36); we suggest that EGF-R could provide the upstream signaling for those responses. Additional studies will be required to evaluate the relationship of various inflammatory stimuli to the EGF-R system.
Hypersecretion is a major manifestation in many chronic inflammatory diseases of airways. Presently, there is no effective therapy to relieve the symptoms and to halt the progression of these diseases. Our findings provide a mechanism and a strategy for therapy: by inhibiting EGF-R activation, gobletcell production is prevented. Inhibition of EGF-R activation is proposed as therapy in hypersecretory airway diseases. Proof of concept in humans will require testing in patients with hypersecretory diseases.
